C

Collate

AISan Francisco, United States· B2B

Collate is an AI startup that develops tools to automate paperwork in the life sciences sector. The company targets pharmaceutical companies, medical device manufacturers, and biotech firms, aiming to streamline regulatory filings and clinical trials. With a recent funding round of $95 million, Collate is positioned to capitalize on the growing demand for AI solutions in life sciences documentation.

$95M · Series BVisit website ↗

🏆 Featured in Datapile’s Q2 2026 USA Funding Report

Read the Q2 2026 USA report →
Add this badge to your site
<a href="https://datapile.co/reports/q2-2026-usa-startup-funding" target="_blank" rel="noopener" style="display:inline-flex;align-items:center;gap:8px;padding:9px 16px;border-radius:9999px;background:#0B1224;color:#ffffff;font:600 13px/1.2 -apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,Arial,sans-serif;text-decoration:none;border:1px solid #7C5CFF"><span style="display:inline-block;width:11px;height:11px;border-radius:3px;background:#7C5CFF"></span>Featured in Datapile&rsquo;s Q2 2026 USA Funding Report</a>

Funding history

  1. $95MSeries B2026-06-03
    Source: news.google.com

Founder

S
Surbhi Sarna
Co-founder

Investors in Collate

Backers from this company's tracked funding rounds.

  • Redpoint Ventures

More AI companies

Recently funded startups in the same category.

Related on Datapile